Edwards Lifesciences (EW) Tops Q1 EPS by 10c; Raises Outlook
Tweet
Share
E-mail
Get Alerts EW Hot Sheet
Price: $87.36 --0%
Revenue Growth %: +11.1%
Financial Fact:
Basic (in shares): 213.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.1%
Financial Fact:
Basic (in shares): 213.2M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $1.32, $0.10 better than the analyst estimate of $1.22. Revenue for the quarter came in at $993 million versus the consensus estimate of $989.61 million.
GUIDANCE:
Edwards Lifesciences sees FY2019 EPS of $5.10-$5.35, from $5.05 to $5.30 and versus the consensus of $5.21.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- Goldman Sachs Double Upgrades Bradsaude SA (SAUD3:BZ) to Buy
- Wall Street scrambles to lift Micron price targets ahead of earnings
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
